Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIRRORS-RCT (Pilot): Randomised Controlled Trial (RCT) of Robotic Interval Cytoreductive Surgery for Advanced Ovarian, Fallopian Tube and Peritoneal Cancer (EOC) Following MIRRORS-protocol vs Standard Open Interval Cytoreductive Surgery

NCT05960630 is registered in ClinicalTrials.gov with Royal Surrey County Hospital NHS Foundation Trust as lead sponsor.

NCT NCT05960630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05960630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIRRORS-RCT (Pilot): Randomised Controlled Trial (RCT) of Robotic Interval Cytoreductive Surgery for Advanced Ovarian, Fallopian Tube and Peritoneal Cancer (EOC) Following MIRRORS-protocol vs Standard Open Interval Cytoreductive Surgery
Lead sponsor
Royal Surrey County Hospital NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
October 2, 2023
Completion date
December 31, 2024
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, fallopian tube neoplasms, ovarian cancer, ovarian neoplasm, ovarian neoplasm epithelial, peritoneal cancer